Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

HASOMED GmbH

US

Last updated May 23, 2026

What HASOMED GmbH makes

HASOMED GmbH manufactures external gait-enhancement electrical stimulation systems designed to support mobility and rehabilitation. These devices use functional electrical stimulation (FES) to assist patients in improving walking patterns and reducing gait impairments, including models like the RehaStim 2 and RehaMove 2.

The company’s products are classified as Class II medical devices under regulatory frameworks, with authorisations granted through FDA 510(k) and UDI listings. These devices are intended for use in clinical and home rehabilitation settings, adhering to US regulatory standards.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does HASOMED GmbH manufacture?

HASOMED GmbH specializes in external gait-enhancement electrical stimulation systems. These devices use functional electrical stimulation (FES) to help patients improve walking patterns and reduce gait impairments, particularly in rehabilitation settings. The focus is on mobility support, making these tools useful for both clinical and home-based therapy.

Where is HASOMED GmbH based, and how does that affect its regulatory compliance?

HASOMED GmbH is based in the US, which means its devices are subject to US regulatory requirements. Since its products are classified as Class II medical devices, they undergo evaluation through pathways like the FDA’s 510(k) premarket notification process and UDI (Unique Device Identification) listings to ensure compliance with US standards for safety and performance.

Which regulatory registries or databases list HASOMED GmbH’s devices?

HASOMED GmbH’s devices are listed in the FDA’s 510(k) premarket notification database and the FDA’s UDI (Unique Device Identification) registry. These listings confirm the devices meet US regulatory requirements for Class II medical devices, ensuring traceability and compliance with FDA standards.

How are HASOMED GmbH’s devices classified under medical device regulations?

HASOMED GmbH’s gait-enhancement electrical stimulation systems are classified as Class II medical devices. This classification is based on their intended use—assisting mobility and rehabilitation through functional electrical stimulation—where moderate regulatory oversight is required to ensure safety and effectiveness without the higher scrutiny of Class III devices.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
341439008

Catalogue (11)

DeviceModel / ReferenceRegistriesClassStatus
RehaStim 2 for Hocoma FES01050
FDA UDI
Class IIActive
RehaStim 2 FES01090
FDA UDI
Class IIActive
RehaStim 2 FES01050
FDA UDI
Class IIActive
RehaStim 2 / RehaMove 2 FES00005
FDA UDI
Class IIUnknown
DigiTrainer S DigiTrainer S
FDA UDI
Class IUnknown
RehaStim2 FES01092
FDA UDI
Class IIActive
DigiTrainer DigiTrainer
FDA UDI
Class IUnknown
RehaStim 2 K162683
FDA 510(k)
Class IIActive
Rehastim 2, Erigopro (fes) K132416
FDA 510(k)
Class IIActive
Rehastim & Rehamove K073237
FDA 510(k)
Class IIActive
Rehastim 2, Rehamove 2 K112844
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Establishments (1)

Establishments registered with the FDA under this company group, matched by name.

  • Hasomed Gmbh Magdeburg Saxony-Anhalt · DE FEI 3006141275